Meiruo Liu

发表论文 5 篇 · 总被引 58 次 · h-index 2

代表论文

• Phase I trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in DLL3-positive small-cell lung cancer and neuroendocrine carcinomas. (2022 · Future Oncology · 被引 59)
• Abstract CT279: DareonTM-5: An open-label phase 2 trial of BI 764532, a DLL3-targeting T-cell engager, in patients (pts) with relapsed/refractory small cell lung cancer or other neuroendocrine carcinomas (2024 · Cancer Research · 被引 2)
• Abstract LB_A16: DareonTM-5: An open-label Phase II trial of BI 764532, a DLL3-targeting T cell engager, in patients with relapsed/refractory small cell lung cancer or other neuroendocrine carcinomas (2023 · Molecular Cancer Therapeutics · 被引 1)
• CTIM-30. A PHASE 1B, OPEN-LABEL, DOSE-ESCALATION TRIAL OF THE DELTA-LIKE LIGAND 3 (DLL3)/CD3 IGG-LIKE T CELL ENGAGER, BI 764532, IN PATIENTS WITH DLL3-POSITIVE GLIOMA (2023 · Neuro-Oncology)
• 贝叶斯方法在肿瘤新药早期临床研发中的发展与应用 (2022 · Zhongguo fei ai za zhi = Chinese journal of lung cancer)